scholarly journals Plyometrics and lifestyle effects on bone mineral density among premenopausal women: demographic and physiological analysis

2020 ◽  
Vol 11 (3) ◽  
pp. 4126-4134
Author(s):  
Golda sahaya Rani R ◽  
Aruna S ◽  
Vijayaraghavan R

Bones have a numerous significant functions in the body such as supporting and protecting various organs of the body. Osteoporosis is a disease of bone characterized by low bone mass and micro-architectural deterioration of bone tissue, that leads to enhanced bone fragility and increased likelihood of fractures. Osteoporosis may be caused due to lower than the normal peak bone mass. Low bone mass results in faster rate of bone porosity and predisposes to osteoporotic fractures. Plyometrics is one of the most effective types of exercises for stimulating bone growth .The aim of the study was first to evaluate the effectiveness of plyometrics benefits on physiological parameters of osteoporosis among premenopausal women. Second to find out the association between the physiological parameters of osteoporosis among premenopausal women with selected demographic variables. The research approach was a Quantitative approach. Design adapted for the study was a true Experimental design with one control group and one experimental group. Data collected from 40 self help group women who were the members of kanchi sangamam from a selected area at chennai.sample were collected by using simple random technique.Based on the inclusion criteria and availability of premenopausal women, they were allocated into the control group (n=20) and experimental group (n=20)..plyometrics was given to the experimental group for 12 weeks. The control group did not receive an intervention. it was analyzed by descriptive and inferential statistics The study determined there is significant changes in physiological parameters of osteoporosis among the experimental group(p<0.001).as compared to the control group The study concluded that was an improvement in bone mineral density at the end of intervention.

Author(s):  
Hsin-Hua Chou ◽  
Sao-Lun Lu ◽  
Sen-Te Wang ◽  
Ting-Hsuan Huang ◽  
Sam Li-Sheng Chen

The association between osteoporosis and periodontal disease (PD) has been revealed by previous studies, but there have been few studies on the association in younger adults. We enrolled a total of 7298 adults aged 40 to 44 who underwent PD screening between 2003 and 2008. Data on quantitative ultrasound for the measurement of bone mineral density (BMD) were collected for the diagnostic criteria of osteopenia and osteoporosis. The Community Periodontal Index (CPI) was measured for defining PD. A multiple logistic regression model was used to assess the effect of low bone mass on the risk of PD. Of 7298 enrollees, 31% had periodontal pockets >3 mm, 36.2% had osteopenia, and 2.1% had osteoporosis. The 39.8% of PD prevalence was high in adults with osteoporosis, followed by 33.3% in osteopenia. A negative association was found between BMD and CPI value (p < 0.0001). Low bone mass was associated with the risk of PD (adjusted OR: 1.13; 95% CI:1.02–1.26) after adjusting the confounding factors, including age, gender, education level, overweight, smoking status, past history of osteoporosis, and diabetes mellitus. An association between BMD and PD among young adults was found. An intervention program for the prevention of PD and osteoporosis could be considered starting in young adults.


2020 ◽  
Vol 93 (4) ◽  
pp. 263-271
Author(s):  
Lara E. Graves ◽  
Christie-Lee Wall ◽  
Julie N. Briody ◽  
Bruce Bennetts ◽  
Karen Wong ◽  
...  

Osteogenesis imperfecta (OI) is a heterogenous group of heritable bone dysplasias characterized by bone fragility, typically low bone mass, joint laxity, easy bruising, and variable short stature. Classical OI is caused by autosomal dominant pathogenic variants in <i>COL1A1</i> or <i>COL1A2</i> that result in either reduced production of normal type 1 collagen or structurally abnormal collagen molecules. Pathogenic variants in these genes generally result in low bone mass. Here, we report a family that had 2 affected individuals who presented with minimal trauma fractures and were found to have elevated bone mineral density (BMD) and a previously unreported variant in <i>COL1A2</i> c.3356C&#x3e;T p.(Ala1119Val). We report the change in BMD using dual-energy X-ray and peripheral quantitative computed tomography over a 2.3-year period in the proband. This case report highlights the importance of BMD studies and genetic testing in the diagnostic process for brittle bone disorders.


2013 ◽  
Vol 168 (4) ◽  
pp. 615-620 ◽  
Author(s):  
B Lapauw ◽  
S Vandewalle ◽  
Y Taes ◽  
S Goemaere ◽  
H Zmierczak ◽  
...  

ObjectiveSclerostin inhibits osteoblast differentiation and bone formation. If aberrant sclerostin action is involved in less efficient bone acquisition in men with idiopathic low bone mass, this might be reflected in higher serum sclerostin levels.MethodsIn 116 men with idiopathic osteoporosis (≤65 years old), 40 of their sons and healthy controls, areal bone parameters were measured using dual-energy X-ray absorptiometry, and volumetric and geometric bone parameters were measured using peripheral quantitative computed tomography. Serum analytes were measured using immunoassays and estradiol (E2) levels using liquid chromatography–tandem mass spectrometry.ResultsMen with idiopathic low bone mass had lower levels of sclerostin than the controls (0.54±0.17 vs 0.66±0.23 ng/ml;P<0.001). In both groups, sclerostin levels were strongly associated with age; when adjusting for age, no associations with anthropometrics were observed (P>0.14). In multivariate analyses, sclerostin levels displayed a positive association with whole-body bone mineral content (BMC) and areal BMD (aBMD), as well as with trabecular and cortical volumetric bone mineral density (vBMD) at the tibia in the probands. No clear associations were observed in the control group, neither were sclerostin levels associated with BMC at the radius or lumbar spine (allP>0.11). Testosterone, but not E2, was inversely related to sclerostin levels in the probands. No difference in sclerostin levels was found in their sons when compared with their controls.ConclusionLower rather than higher serum sclerostin levels in the probands with idiopathic low bone mass suggest that aberrant sclerostin secretion is not involved in the pathogenesis of low bone mass in these subjects.


Bone ◽  
2021 ◽  
Vol 143 ◽  
pp. 115782
Author(s):  
Salvador Israel Macías-Hernández ◽  
Rafael Zepeda-Mora ◽  
Laura Torres-Mondragón ◽  
Gerardo Martínez Morales ◽  
Karina Tolentino-Bazan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document